AXSOME THERAPEUTICS INC (AXSM)

Sector: Health Care

Name	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
Herriot Tabuteau, M.D.	Chief Executive Officer, President and Chairman of our Board of Directors; Chief Executive Officer, President, and Chairman of the Board	57	["Founder of Antecip Capital LLC","Managing member of Antecip Bioventures II LLC","Senior Analyst and Partner at Healthco/S.A.C. Capital","Healthcare analyst at Kingdon Capital","Senior Research Analyst at Bank of America Securities","Part of healthcare investment banking group at Goldman Sachs","M.D. from Yale University School of Medicine","Bachelor of Arts in molecular biology and biochemistry from Wesleyan University"]	[]	2026
Mark Coleman, M.D.	Medical Director of the Pikesville office of National Spine and Pain Centers	58	["Consultant from 2012 to 2014","Former President of NSPC","Former Director of Clinical Services of NSPC","Diplomat of the American Board of Anesthesiology in Anesthesiology and Pain Management","M.D. from Johns Hopkins University School of Medicine","Undergraduate degree from Wesleyan University"]	[]	2026
Mark Saad	Director	56	["CEO of NuLids, LLC","Former Chief Financial Officer of Bird Rock Bio, Inc.","Former Chief Financial Officer of Cytori Therapeutics","Executive Director at UBS Investment Bank","Experience in healthcare investment banking"]	[]	2026
Roger Jeffs, Ph.D.	Chief Executive Officer	64	["Chief Executive Officer of Liquidia Corporation since January 2022","Co-Founder and Vice Chairman of Kriya Therapeutics","Previous experience at United Therapeutics Corporation for 18 years","Director of Research, Development, and Medical at United Therapeutics","President and Chief Operating Officer at United Therapeutics from 2001 to 2014","President and co-CEO at United Therapeutics from 2015 to 2016","Oversaw clinical development and regulatory approval of 6 products for rare diseases","Experience held positions at Amgen, Inc. and Burroughs Wellcome Co.","Undergraduate degree in chemistry from Duke University","Ph.D. in pharmacology from the University of North Carolina School of Medicine"]	[]	2026
Susan Mahony, Ph.D., MBA	Director	61	["Former President of Lilly Oncology","Experience in leadership positions at Eli Lilly and Company","Led commercial activities at Bristol Myers Squibb","Experience in sales and marketing at Amgen and Schering Plough","Doctor of Philosophy in Oncology and MBA"]	[]	2026

Name

Position

Age

Qualifications and Experience

Committee Memberships

Filing Year

Chief Executive Officer, President and Chairman of our Board of Directors; Chief Executive Officer, President, and Chairman of the Board

["Founder of Antecip Capital LLC","Managing member of Antecip Bioventures II LLC","Senior Analyst and Partner at Healthco/S.A.C. Capital","Healthcare analyst at Kingdon Capital","Senior Research Analyst at Bank of America Securities","Part of healthcare investment banking group at Goldman Sachs","M.D. from Yale University School of Medicine","Bachelor of Arts in molecular biology and biochemistry from Wesleyan University"]

[]

2026

Mark Coleman, M.D.

Medical Director of the Pikesville office of National Spine and Pain Centers

["Consultant from 2012 to 2014","Former President of NSPC","Former Director of Clinical Services of NSPC","Diplomat of the American Board of Anesthesiology in Anesthesiology and Pain Management","M.D. from Johns Hopkins University School of Medicine","Undergraduate degree from Wesleyan University"]

[]

2026

Mark Saad

Director

["CEO of NuLids, LLC","Former Chief Financial Officer of Bird Rock Bio, Inc.","Former Chief Financial Officer of Cytori Therapeutics","Executive Director at UBS Investment Bank","Experience in healthcare investment banking"]

[]

2026

Roger Jeffs, Ph.D.

Chief Executive Officer

["Chief Executive Officer of Liquidia Corporation since January 2022","Co-Founder and Vice Chairman of Kriya Therapeutics","Previous experience at United Therapeutics Corporation for 18 years","Director of Research, Development, and Medical at United Therapeutics","President and Chief Operating Officer at United Therapeutics from 2001 to 2014","President and co-CEO at United Therapeutics from 2015 to 2016","Oversaw clinical development and regulatory approval of 6 products for rare diseases","Experience held positions at Amgen, Inc. and Burroughs Wellcome Co.","Undergraduate degree in chemistry from Duke University","Ph.D. in pharmacology from the University of North Carolina School of Medicine"]

[]

2026

Susan Mahony, Ph.D., MBA

Director

["Former President of Lilly Oncology","Experience in leadership positions at Eli Lilly and Company","Led commercial activities at Bristol Myers Squibb","Experience in sales and marketing at Amgen and Schering Plough","Doctor of Philosophy in Oncology and MBA"]

[]

2026